About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT06503640

Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)

The goal of this observational study is to explore the incidence and effect on prognosis of coronary microvascular dysfunction in patients present of stable anginal symptoms, a clinical indication for...

Lead sponsor: China-Japan Friendship Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Zhaoxue Sheng, Doctor

CONTACT

+86-15600268925 shengzhaoxue@163.com

Sponsors

Lead Sponsor

China-Japan Friendship Hospital

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•presence of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) \>0.80

Exclusion Criteria

•1. acute myocardial infarction
•2. significant valvular heart disease
•3. advanced chronic kidney disease
•4. patients with significant epicardial coronary artery stenosis (\>70% in major vessels by diagnostic coronary angiography) needing percutaneous coronary intervention
•5. patients unable to provide written informed consent

Related studies

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

NCT07093528 · Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

NCT06991322 · Coronary Microvascular Dysfunction, Coronary Microvascular Disease

RECRUITINGPhase 4

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.

NCT05984537 · Coronary Microvascular Dysfunction

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

NCT06795035 · ST Elevation Myocardial Infarction, Coronary Microvascular Dysfunction, and more

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

NCT06597851 · Coronary Microvascular Dysfunction, Coronary Microvascular Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 16, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment100

Start dateJul 2023

Last updatedJul 16, 2024

Condition

Angina Patients With Non-obstructive Coronary Artery Disease Coronary Microvascular Dysfunction Index of Microvascular Resistance

Locations shown

China-Japan Friendship Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 16, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions